Yi Chen
Stock Analyst at HC Wainwright & Co.
(3.37)
# 984
Out of 4,711 analysts
420
Total ratings
36.12%
Success rate
7%
Average return
Main Sectors:
Stocks Rated by Yi Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VERU Veru Inc. | Reiterates: Buy | $3 | $0.65 | +362.18% | 19 | Dec 20, 2024 | |
| BLCO Bausch + Lomb | Reiterates: Buy | $23 | $18.00 | +27.78% | 15 | Dec 12, 2024 | |
| TRML Tourmaline Bio | Reiterates: Buy | $49 | $20.65 | +137.29% | 5 | Dec 11, 2024 | |
| ANGO AngioDynamics | Reiterates: Buy | $14 | $8.89 | +57.48% | 8 | Dec 10, 2024 | |
| ZYXI Zynex | Reiterates: Buy | $17 | $8.25 | +106.06% | 20 | Dec 6, 2024 | |
| EYPT EyePoint Pharmaceuticals | Reiterates: Buy | $22 | $7.10 | +209.86% | 20 | Dec 5, 2024 | |
| OCUL Ocular Therapeutix | Reiterates: Buy | $15 | $8.50 | +76.47% | 25 | Dec 3, 2024 | |
| LEXX Lexaria Bioscience | Reiterates: Buy | $10 | $2.23 | +348.43% | 4 | Dec 2, 2024 | |
| ICCM IceCure Medical | Reiterates: Buy | $2.5 | $1.12 | +123.21% | 19 | Nov 27, 2024 | |
| MYNZ Mainz Biomed | Downgrades: Neutral | n/a | $6.68 | - | 10 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $3.10 | +190.32% | 16 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $36 | $7.62 | +372.44% | 7 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.69 | +160.22% | 17 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.11 | +350.45% | 11 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $11 | $7.10 | +54.93% | 17 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.92 | +153.38% | 19 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $4.92 | +184.55% | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.87 | +587.84% | 18 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $100 | $64.12 | +55.96% | 17 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.27 | +205.81% | 15 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $16.98 | +76.68% | 11 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $5.04 | +138.10% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $1.5 | $0.73 | +105.48% | 22 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $1.18 | +154.24% | 1 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.06 | +560.38% | 9 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $20.61 | - | 9 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.54 | +94.81% | 9 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $38 | $12.39 | +206.70% | 6 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $1.5 | $0.18 | +746.98% | 18 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.91 | +998.90% | 5 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.61 | +1,701.80% | 14 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.59 | - | 7 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $180 | $1.26 | +14,185.71% | 1 | May 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $18.70 | +156.68% | 8 | Apr 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $8 | $0.09 | +9,278.66% | 5 | Apr 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $12.46 | +52.49% | 2 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.36 | - | 2 | Apr 16, 2020 |
Veru Inc.
Dec 20, 2024
Reiterates: Buy
Price Target: $3
Current: $0.65
Upside: +362.18%
Bausch + Lomb
Dec 12, 2024
Reiterates: Buy
Price Target: $23
Current: $18.00
Upside: +27.78%
Tourmaline Bio
Dec 11, 2024
Reiterates: Buy
Price Target: $49
Current: $20.65
Upside: +137.29%
AngioDynamics
Dec 10, 2024
Reiterates: Buy
Price Target: $14
Current: $8.89
Upside: +57.48%
Zynex
Dec 6, 2024
Reiterates: Buy
Price Target: $17
Current: $8.25
Upside: +106.06%
EyePoint Pharmaceuticals
Dec 5, 2024
Reiterates: Buy
Price Target: $22
Current: $7.10
Upside: +209.86%
Ocular Therapeutix
Dec 3, 2024
Reiterates: Buy
Price Target: $15
Current: $8.50
Upside: +76.47%
Lexaria Bioscience
Dec 2, 2024
Reiterates: Buy
Price Target: $10
Current: $2.23
Upside: +348.43%
IceCure Medical
Nov 27, 2024
Reiterates: Buy
Price Target: $2.5
Current: $1.12
Upside: +123.21%
Mainz Biomed
Nov 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.68
Upside: -
Nov 22, 2024
Reiterates: Buy
Price Target: $9
Current: $3.10
Upside: +190.32%
Nov 21, 2024
Maintains: Buy
Price Target: $40 → $36
Current: $7.62
Upside: +372.44%
Nov 19, 2024
Reiterates: Buy
Price Target: $7
Current: $2.69
Upside: +160.22%
Nov 19, 2024
Reiterates: Buy
Price Target: $5
Current: $1.11
Upside: +350.45%
Nov 18, 2024
Maintains: Buy
Price Target: $10 → $11
Current: $7.10
Upside: +54.93%
Nov 15, 2024
Reiterates: Buy
Price Target: $15
Current: $5.92
Upside: +153.38%
Nov 15, 2024
Reiterates: Buy
Price Target: $14
Current: $4.92
Upside: +184.55%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $0.87
Upside: +587.84%
Nov 13, 2024
Maintains: Buy
Price Target: $60 → $100
Current: $64.12
Upside: +55.96%
Nov 12, 2024
Reiterates: Buy
Price Target: $10
Current: $3.27
Upside: +205.81%
Nov 11, 2024
Reiterates: Buy
Price Target: $30
Current: $16.98
Upside: +76.68%
Nov 11, 2024
Reiterates: Buy
Price Target: $12
Current: $5.04
Upside: +138.10%
Nov 11, 2024
Reiterates: Neutral
Price Target: $1.5
Current: $0.73
Upside: +105.48%
Nov 7, 2024
Initiates: Buy
Price Target: $3
Current: $1.18
Upside: +154.24%
Oct 24, 2024
Reiterates: Buy
Price Target: $7
Current: $1.06
Upside: +560.38%
Oct 22, 2024
Reiterates: Neutral
Price Target: n/a
Current: $20.61
Upside: -
Sep 26, 2024
Reiterates: Buy
Price Target: $3
Current: $1.54
Upside: +94.81%
Aug 23, 2024
Maintains: Buy
Price Target: $36 → $38
Current: $12.39
Upside: +206.70%
Jun 10, 2024
Maintains: Buy
Price Target: $7 → $1.5
Current: $0.18
Upside: +746.98%
May 17, 2024
Reiterates: Buy
Price Target: $10
Current: $0.91
Upside: +998.90%
Feb 21, 2024
Reiterates: Buy
Price Target: $11
Current: $0.61
Upside: +1,701.80%
Jun 7, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.59
Upside: -
May 19, 2022
Maintains: Buy
Price Target: $240 → $180
Current: $1.26
Upside: +14,185.71%
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $18.70
Upside: +156.68%
Apr 1, 2021
Maintains: Buy
Price Target: $6 → $8
Current: $0.09
Upside: +9,278.66%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $12.46
Upside: +52.49%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.36
Upside: -